BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 15699349)

  • 1. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.
    Kapadia SB; Chisari FV
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2561-6. PubMed ID: 15699349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
    Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
    Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis.
    Moriishi K; Mochizuki R; Moriya K; Miyamoto H; Mori Y; Abe T; Murata S; Tanaka K; Miyamura T; Suzuki T; Koike K; Matsuura Y
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1661-6. PubMed ID: 17234812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
    J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.
    Chang KO; George DW
    J Virol; 2007 Sep; 81(18):9633-40. PubMed ID: 17609266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR.
    Ou J; Tu H; Shan B; Luk A; DeBose-Boyd RA; Bashmakov Y; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6027-32. PubMed ID: 11371634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subgenomic replicon derived from a cell line infected with the hepatitis C virus.
    Kishine H; Sugiyama K; Hijikata M; Kato N; Takahashi H; Noshi T; Nio Y; Hosaka M; Miyanari Y; Shimotohno K
    Biochem Biophys Res Commun; 2002 May; 293(3):993-9. PubMed ID: 12051758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.
    Ye J; Wang C; Sumpter R; Brown MS; Goldstein JL; Gale M
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15865-70. PubMed ID: 14668447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication.
    Sagan SM; Rouleau Y; Leggiadro C; Supekova L; Schultz PG; Su AI; Pezacki JP
    Biochem Cell Biol; 2006 Feb; 84(1):67-79. PubMed ID: 16462891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.
    Hofmann S; Krajewski M; Scherer C; Scholz V; Mordhorst V; Truschow P; Schöbel A; Reimer R; Schwudke D; Herker E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1041-1056. PubMed ID: 29885363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of hepatitis C virus RNA replication by short interfering RNAs.
    Kapadia SB; Brideau-Andersen A; Chisari FV
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2014-8. PubMed ID: 12566571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon regulatory factor 3-independent double-stranded RNA-induced inhibition of hepatitis C virus replicons in human embryonic kidney 293 cells.
    Ali S; Kukolj G
    J Virol; 2005 Mar; 79(5):3174-8. PubMed ID: 15709037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the interferon-beta promoter during hepatitis C virus RNA replication.
    Fredericksen B; Akkaraju GR; Foy E; Wang C; Pflugheber J; Chen ZJ; Gale M
    Viral Immunol; 2002; 15(1):29-40. PubMed ID: 11952144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of U2OS and Huh-7 cells for identifying host factors that affect hepatitis C virus RNA replication.
    Jones DM; Domingues P; Targett-Adams P; McLauchlan J
    J Gen Virol; 2010 Sep; 91(Pt 9):2238-48. PubMed ID: 20505011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons.
    Gosert R; Egger D; Lohmann V; Bartenschlager R; Blum HE; Bienz K; Moradpour D
    J Virol; 2003 May; 77(9):5487-92. PubMed ID: 12692249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.
    Porstmann T; Griffiths B; Chung YL; Delpuech O; Griffiths JR; Downward J; Schulze A
    Oncogene; 2005 Sep; 24(43):6465-81. PubMed ID: 16007182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hepatitis C virus replication by interferon regulatory factor 1.
    Kanazawa N; Kurosaki M; Sakamoto N; Enomoto N; Itsui Y; Yamashiro T; Tanabe Y; Maekawa S; Nakagawa M; Chen CH; Kakinuma S; Oshima S; Nakamura T; Kato T; Wakita T; Watanabe M
    J Virol; 2004 Sep; 78(18):9713-20. PubMed ID: 15331704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.